References
- Falcone T., Fincgood D. T., Fantus G., Morris D. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women. J. Clin. Endocrinol, McTab. 1990; 71: 1653–7
- Falcone T., Little A. B., Moms D. Impaired glucose effectiveness in patients with polycystic ovary syndrome. Hum. Reprod. 1992; 7: 922–5
- Hamilton-Fairley D., Kiddy D. S., Anyaoku V., Koistinen R., Seppala M., Franks S. Response of sex hormone binding globulin and insulin like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction. Clin. Endocrinol. 1993; 39: 363–7
- Flernandez E. R., Resnick C. E., Svoboda M. E., VanWyk J. J., Payne D. W., Adashi E. Y. Somatomedin C/msulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells. Endocrinology 1988; 122: 1603–12
- Homburg R., Pariente C., Lunenfeld B., Jacobs H. S. The role ofinsulin like growth factor-I (IGF-I) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of PCO. Hum. Reprod. 1992; 10: 1379–83
- Suikkari A. M., Koivisto V. A., Rutanen E. M., YkiJarvinen H., Karonen S. L., Sepala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J. Clin. Endocrinol. Metab. 1988; 66: 266
- Suikkari A. M., Koivisto V. A., Koistinen R., Seppälä M. Yki, Jarvinen H. Dose response characteristics for suppression of low molecular weight plasma insulin-like growth factor binding protein by insulin. J. Clin. Endocrinol. Metab. 1989; 68: 135–40
- Kiddy D. S., Hamilton-Fairley D., Seppälä M., Koistinen R., James V. H., Reed M. J., Frank S. Diet induced changes in SHBG and free testosterone in women with normal or polycystic ovaries correlation with insulin and insulin-like growth factor I. Clin. Endocrinol. 1989; 31: 757–63
- Conover C. A., Lee P. D. K., Kanaley J. A., Clarkson J. T., Jensen M. B. Insulin regulation of insulin like growth factor binding protein-1 in obese and nonobese humans. J. Clin. Endocrinol. Metab. 1992; 74: 1355–60
- Conway G. S., Jacobs H. S., Holly J. M. P., Wass J. A. H. Effects of lutenizing hormone, insulin, insulin like growth factor-I and insulin like growth factor small binding protein 1 in the PCO syndrome. Clin. Endocrinol. 1990; 33: 593–603
- Bergman R. N., Prager R., Volund A., Olefsky J. M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 1987; 79: 790–800
- Cottenll A. M., Holly J. M. P., Wass J. A. H. The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fast. Clin. Endocrinol. 1989; 31: 357–62
- Miller J. D., Tannenbaum G S., Colle E., Guyda H. J. Daytime pulsatile growth hormone secretion during childhood and adolescence. J. Clin. Endocrinol. Metab. 1982; 55: 989–93
- Tulandi T., Falcone T., Guyda H., Hemmings R., Billiar R. B., Morris D. Effect of synthetic growth hormone-releasing factor in women treated with gonado-tropin. Hum. Reprod. 1993; 4: 525–7
- Synder D. K., Clemmons D. R. Insulin dependent regulation of insulin-like growth factor binding protein-1. J. Clin. Endocrinol. Metab. 1990; 71: 1632–6
- Ovesen P., Moller J., Ingerslev H. J., Jorgensen J. O., Mengel A., Schmitz O., Alberti K. G., Moller N. Normal basal and insulin stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1993; 77: 1636–40
- Smith S., Ravnikar V. A., Barbieri R. L. Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertil. Steril. 1987; 48: 72–4
- Herbert C. M., Hill G. A., Diamond M. P. The use of the intravenous glucose tolerance test to evaluate nonobese hyperandrogenic women. Fertil. Steril. 1990; 53: 644–53
- Tiitinen A. E., Laatikainen T. J., Seppälä M. T. Serum levels of insulin-like growth factor binding protein 1 and ovulatory responses to clomiphene citrate in women with PCO. Fertil. Steril. 1993; 60: 58–62